Novo Nordisk recently sued the popular American telehealth company Hims & Hers Health for selling unsafe, knock-off versions of their GLP-1 medications, according to Novo Nordisk
However, the panel opted not to include cases involving blood clot injuries, such as deep vein thrombosis and pulmonary embolism, due to concerns about added complexity in the litigation
With tirzepatide, patients can achieve substantial, sustainable weight loss, surpassing results from other single-agent medications
Your provider will set realistic timelines up front so you know what to look for and when to reassess if youre not seeing the impact you hoped for
In terms of insulin sensitivity, many studies corroborate Akkermansia supplementation with improved HOMA-IR and plasma insulin
We look forward to meeting you and helping you achieve your health and wellness goals